• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Slight increase of incidence of myocarditis post-mRNA SARS-CoV-2 vaccination

byDavy LauandAlex Chan
December 15, 2022
in Cardiology, Infectious Disease, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. The incidence of myocarditis following administration of mRNA SARS-CoV-2 vaccine was higher than the baseline incidence.

2. Rates of myocarditis were higher amongst males, individuals aged 12-29 years old, patients receiving the Moderna mRNA-1273 vaccine, and following the second dose.

Evidence Rating Level: 2 (Good)

Study Rundown: Postvaccination myocarditis has been identified as an adverse event associated with the mRNA SARS-CoV-2 vaccines, produced by Pfizer-BioNTech (BNT162b2) and Moderna (mRNA-1273), particularly in adolescents and younger adults. However, the evidence stems mainly from case reports and case series, and there is also insufficient data on myocarditis occurrence after the third vaccine dose. Therefore, this observed-to-expected analysis compared the cases of post-SARS-CoV-2 vaccination myocarditis, against a calculated number of cases under the null hypothesis, if there were no association between myocarditis and vaccination. This calculation was performed using background rates of myocarditis ER visits and admissions from 2019, in the same population. The primary outcome was an emergency room visit or hospital admission for myocarditis, which may have resulted in missing milder cases that were diagnosed in an outpatient context. The study found an observed to expected case ratio of 7.03. The incidence was higher for individuals aged 12-29 years compared to older adults, for males compared to females, and for the second compared to third dose. The highest ratio was observed for males 18-29 years old following their second dose, with an mRNA-1273 vaccine. Overall, this study demonstrated that the incidence of myocarditis after vaccination with mRNA SARS-CoV-2 vaccines were higher than expected, and were highest in males, in those aged 12-29 years, after the mRNA-1273 vaccine, and after the second vaccine dose.

Click here to read the study in CMAJ

Relevant Reading: Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID-19 vaccine

RELATED REPORTS

#VisualAbstract: Obicetrapib Reduced LDL Cholesterol in Patients at High Cardiovascular Risk

Living in a marginalized neighbourhood is associated with worse outcomes in patients with myocardial infarction

Mazdutide significantly reduces weight in adults with overweight or obesity

In-Depth [retrospective cohort]: The study population consisted of individuals 12 years and older, receiving a BNT162b2 or mRNA-1273 vaccine between December 2020 and March 2022, in British Columbia, Canada. These dates included individuals receiving their 1st, 2nd, and 3rd doses of vaccine. Patients with a history of myocarditis or myopericarditis within 1 year prior to a vaccine dose were excluded. In total, there were 10,255,385 mRNA vaccine doses administered in the study period, with 6,989,921 BNT162b2 vaccines and 3,265,464 mRNA-1273 vaccines. There were 99 myocarditis cases observed within 7 days of vaccine (7 cases expected), and 141 cases within 21 days of vaccine (20 cases expected). This resulted in an incidence of 0.97 myocarditis cases per 100,000 vaccine doses within 7 days, and 1.37 cases per 100,000 vaccine doses within 21 days. The ratio of observed to expected cases was 7.03. Rates of myocarditis at 7 days was higher for males than females (1.64, 95% CI 1.30-2.04 vs 0.35, 95% CI 0.21-0.55), and highest among those aged 12-17 (2.64, 95% CI 1.54-4.22) and 18-29 (2.63, 95% CI 1.94-3.50) years. As well, rates were higher for the mRNA-1273 vaccine compared to the BNT162b2 vaccine (1.44, 95% CI 1.06-1.91 vs 0.74, 95% CI 0.56-0.98), with the largest difference after the second dose in males 18-29 years old (22.1, 95% CI 14.1-32.8 vs 5.1, 95% CI 2.7-8.7). Furthermore, the rate was higher after the second dose compared to the third dose (1.90, 95% CI 1.50-2.39 vs 0.76, 95% CI 0.45-1.20).

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiologyCOVID-19MyocarditisSARS-CoV-2
Previous Post

#VisualAbstract: Oral antibiotic prophylaxis may reduce incidence of surgical site infections

Next Post

The 2 Minute Medicine Podcast Episode 4

RelatedReports

#VisualAbstract: Obicetrapib Reduced LDL Cholesterol in Patients at High Cardiovascular Risk
StudyGraphics

#VisualAbstract: Obicetrapib Reduced LDL Cholesterol in Patients at High Cardiovascular Risk

July 15, 2025
Cardiology

Living in a marginalized neighbourhood is associated with worse outcomes in patients with myocardial infarction

July 12, 2025
Increasing maternal BMI linked to higher risk of cerebral palsy
Cardiology

Mazdutide significantly reduces weight in adults with overweight or obesity

July 11, 2025
Cerebral protection device effective in patients undergoing transcatheter aortic valve implantation
Cardiology

Cerebral embolic protection does not decrease stroke incidence in TAVI patients

July 8, 2025
Next Post

The 2 Minute Medicine Podcast Episode 4

Adolescent mothers in protective care more likely to have their children placed in care

Juvenile idiopathic arthritis may be associated with an increased risk of obstructive sleep apnea

Metronome use linked to rate optimization in pediatric CPR

Smartphone volunteer app dispatches may increase Automated External Defibrillator use

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Thrombolysis-to-puncture time greater than 70 minutes decreases odds of successful thrombectomy
  • #VisualAbstract: Obicetrapib Reduced LDL Cholesterol in Patients at High Cardiovascular Risk
  • St. Louis hospital-based violence intervention program did not significantly affect reinjury outcomes
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.